We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App


31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Wireless Implantable LED Device Treats Deep-Seated Cancers Using Light

By HospiMedica International staff writers
Posted on 10 Jul 2024
Print article
Image: The wireless implantable LED-device when combined with a light-sensitive dye destroys cancer cells (Photo courtesy of University of Notre Dame)
Image: The wireless implantable LED-device when combined with a light-sensitive dye destroys cancer cells (Photo courtesy of University of Notre Dame)

Certain types of light, when used in conjunction with a light-activated drug, have been shown to be an effective, minimally invasive treatment for cancers situated on or just beneath the skin. However, cancers that are deep-seated and shielded by layers of tissue, blood, and bone have historically been unreachable by light-based treatments. To extend the therapeutic benefits of light to these more inaccessible cancers, a team of engineers and scientists has developed a wireless, implantable LED device. This innovative device, when used alongside a light-sensitive dye, not only kills cancer cells but also stimulates the immune system’s cancer-targeting response.

Some colors of light have been found to penetrate tissue deeper than others. Green light, which does not penetrate very deeply, is particularly effective at eliciting a strong anti-cancer response. However, before the light can effectively destroy cancer cells, the cells must be treated with a dye that contains light-absorbing molecules. Engineers and scientists at the University of Notre Dame (Notre Dame, IN, USA) have created a device that activates this dye, converting the light into energy that converts the cells’ own oxygen into a toxic agent, thereby turning the cancer cells against themselves. While other treatments also use the cells' oxygen in a similar manner, this device uniquely induces a type of cell death that is especially beneficial.

In their research published in Photodiagnosis and Photodynamic Therapy, the team observed that the treated cells exhibited swelling, indicative of a type of cell death known as pyroptosis. This form of cell death is particularly effective at activating the immune response. The device, small enough to be the size of a grain of rice, can be injected directly into a tumor and activated remotely via an external antenna. The aim is to induce a small amount of pyroptotic cell death, which in turn triggers the immune system to begin attacking the cancer. The device is designed not just to administer treatment but also to monitor the tumor’s response, allowing for adjustments in signal strength and timing as necessary. Future experiments will involve using the device in mice to determine if the immune response triggered in one tumor can encourage the immune system to recognize and attack another cancerous tumor independently.

Gold Member
12-Channel ECG
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
Orthopedic Extension

Print article


Surgical Techniques

view channel
Image: The SIRA RFA electrosurgical device designed specifically for patients undergoing breast-conserving surgery (Photo courtesy of Innoblative Designs)

Novel Electrosurgical Device Could Be a Game-Changer for Breast Cancer Treatment

Breast cancer represents a significant health issue globally, affecting women in every country. After diagnosis, patients face challenging choices about their treatment paths. One common treatment, Breast... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more


view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.